Replimune Group Inc buy BMO Capital Markets
Start price
22.01.25
/
50%
€12.90
Target price
22.01.26
€25.92
Performance (%)
-48.84%
End price
23.01.26
€6.60
Summary
This prediction ended on 23.01.26 with a price of €6.60. The BUY prediction by BMO_Capital_Markets for Replimune Group Inc performed very badly with a performance of -48.84%. BMO_Capital_Markets has a follow-up prediction for Replimune Group Inc, but this time predicts that Replimune Group Inc is a Sell. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Replimune Group Inc | 14.655% | 14.655% | -50.000% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $18.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
In the thread Trading Replimune Group Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Replimune Group Inc
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25
